Is Novo Nordisk Stock a Buy Now?

Last year, Denmark-based biotech giant Novo Nordisk (NYSE: NVO) couldn’t stop grabbing headlines. From the company’s notable work in the market for weight-loss drugs to its meaningful contribution to its country’s economy, Novo Nordisk got plenty of accolades that translated to a